Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis

  title={Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis},
  author={Amer M. Awad and B. Hemmer and H. Hartung and B. Kieseier and O. Stuve},
  journal={Journal of Neuroimmunology},
  • Amer M. Awad, B. Hemmer, +2 authors O. Stuve
  • Published 2010
  • Medicine
  • Journal of Neuroimmunology
  • The laboratory evaluation of cerebrospinal fluid (CSF) has been routinely employed as a diagnostic test in the diagnosis of neuroimmunological disorders such as multiple sclerosis (MS). Recently, CSF analyses in MS have garnered renewed interest as a tool for monitoring disease activity and prognosis. With the identification of patients that are very early in their disease course, namely patients with a radiologically isolated (RIS) or a clinically isolated syndrome (CIS), the true value of… CONTINUE READING
    88 Citations
    Updates on Clinically Isolated Syndrome and Diagnostic Criteria for Multiple Sclerosis
    • 27
    • Highly Influenced
    Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases
    • 9
    • PDF
    Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome
    • 11
    Impact of the McDonald Criteria 2017 on Early Diagnosis of Relapsing-Remitting Multiple Sclerosis
    • 13
    • PDF


    Cerebrospinal fluid analysis in multiple sclerosis.
    • 13
    Biological markers to confirm diagnosis and monitor the therapy in multiple sclerosis patients.
    • 9
    • PDF
    Cerebrospinal fluid biomarkers in multiple sclerosis
    • 103
    Evaluation of the clinical utility of cerebrospinal fluid (CSF) indices of inflammatory markers in multiple sclerosis.
    • 18
    • Highly Influential
    Cerebrospinal fluid in multiple sclerosis.
    • 3
    Diagnostic criteria for multiple sclerosis
    • 1,793
    [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].
    • 6
    Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event.
    • 584
    • PDF